Literature DB >> 14962519

Beryllium exposure and chronic beryllium disease.

Peter F Infante1, Lee S Newman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14962519     DOI： 10.1016/S0140-6736(04)15523-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  17 in total

1.  SELDI-TOF derived serum biomarkers failed to differentiate between patients with beryllium sensitisation and patients with chronic beryllium disease.

Authors:  B C Tooker; R P Bowler; J M Orcutt; L A Maier; H M Christensen; L S Newman
Journal:  Occup Environ Med       Date:  2011-01-27       Impact factor: 4.402

Review 2.  Chronic beryllium disease: an updated model interaction between innate and acquired immunity.

Authors:  Richard T Sawyer; Lisa A Maier
Journal:  Biometals       Date:  2010-10-28       Impact factor: 2.949

3.  Frequency of beryllium-specific, central memory CD4+ T cells in blood determines proliferative response.

Authors:  Andrew P Fontenot; Brent E Palmer; Andrew K Sullivan; Fenneke G Joslin; Cara C Wilson; Lisa A Maier; Lee S Newman; Brian L Kotzin
Journal:  J Clin Invest       Date:  2005-09-08       Impact factor: 14.808

4.  Environment, Epigenetics, and Differential Responses to Beryllium Exposure: Are We There Yet?

Authors:  Samuel Brusca; Sean Agbor-Enoh
Journal:  Am J Respir Cell Mol Biol       Date:  2019-01       Impact factor: 6.914

5.  Beryllium-induced lung disease exhibits expression profiles similar to sarcoidosis.

Authors:  Li Li; Lori J Silveira; Nabeel Hamzeh; May Gillespie; Peggy M Mroz; Annyce S Mayer; Tasha E Fingerlin; Lisa A Maier
Journal:  Eur Respir J       Date:  2016-04-21       Impact factor: 16.671

6.  Distribution and health risk assessment to heavy metals near smelting and mining areas of Hezhang, China.

Authors:  Meryem Briki; Yi Zhu; Yang Gao; Mengmeng Shao; Huaijian Ding; Hongbing Ji
Journal:  Environ Monit Assess       Date:  2017-08-19       Impact factor: 2.513

7.  Function associated transforming growth factor-beta gene polymorphism in chronic beryllium disease.

Authors:  Karoline I Gaede; Massimo Amicosante; Manfred Schürmann; Elisabeth Fireman; Cesare Saltini; Joachim Müller-Quernheim
Journal:  J Mol Med (Berl)       Date:  2005-03-05       Impact factor: 4.599

8.  Accelerator mass spectrometry detection of beryllium ions in the antigen processing and presentation pathway.

Authors:  Brian C Tooker; Stephen M Brindley; Marina L Chiarappa-Zucca; Kenneth W Turteltaub; Lee S Newman
Journal:  J Immunotoxicol       Date:  2014-06-16       Impact factor: 3.000

9.  DNA Methylation Changes in Lung Immune Cells Are Associated with Granulomatous Lung Disease.

Authors:  Ivana V Yang; Iain Konigsberg; Kristyn MacPhail; Li Li; Elizabeth J Davidson; Peggy M Mroz; Nabeel Hamzeh; May Gillespie; Lori J Silveira; Tasha E Fingerlin; Lisa A Maier
Journal:  Am J Respir Cell Mol Biol       Date:  2019-01       Impact factor: 6.914

10.  Impact of negatively charged patches on the surface of MHC class II antigen-presenting proteins on risk of chronic beryllium disease.

Authors:  James A Snyder; Eugene Demchuk; Erin C McCanlies; Christine R Schuler; Kathleen Kreiss; Michael E Andrew; Bonnie L Frye; James S Ensey; Marcia L Stanton; Ainsley Weston
Journal:  J R Soc Interface       Date:  2008-07-06       Impact factor: 4.118
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.